Results 61 to 70 of about 12,460 (245)

SUCCESS RATES OF TAMSULOSIN AND DUTASTERIDE AS MEDICAL THERAPY BASED ON IPSS IN SYMPTOMATIC BPH PATIENTS IN ARIFIN ACHMAD HOSPITAL PEKANBARU RIAU

open access: yesJurnal Urologi Indonesia, 2018
Objective: To evaluate the success rates of tamsulosin and dutasteride as medical therapy based on international prostate symptom score (IPSS) in symptomatic benign prostatic hyperplasia (BPH) patients. Materials & Methods: We reviewed medical records of 
Zuhirman Zamzami
doaj   +1 more source

Tamsulosin � turn a round [PDF]

open access: yes, 2011
Tamsulosin is a sulfamoylphen-ethylamine derivative, a potent and a selective antagonist of Alpha-1A adrenoceptor. It s approved in the treatment of LUTS in BPH disease, being a specific Alpha -1A blocker it does not interfere much with the ...
Praveen R, Int J Cur Bio Med Sci.
core  

European Academy of Neurology (EAN)/European Federation of Autonomic Societies (EFAS)/International Neuro‐Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Guidelines)

open access: yesEuropean Journal of Neurology, Volume 32, Issue 4, April 2025.
ABSTRACT Background Urinary and sexual symptoms are common following neurological disease, and we aimed to develop multidisciplinary inter‐society evidence‐based management guidelines. Methods The ADAPTE framework was used, and a systematic search of guidelines published in different languages was performed.
Jalesh N. Panicker   +35 more
wiley   +1 more source

Clinical use of the beta-3 adrenoceptor agonist mirabegron in patients with overactive bladder syndrome [PDF]

open access: yes, 2015
Mirabegron is a β 3 adrenoceptor agonist licensed for the treatment of overactive bladder symptoms, such as urinary urgency or urgency incontinence. β 3 adrenoceptor activation causes detrusor muscle relaxation, but mirabegron may also act by binding ...
Drake, Marcus, Vij, Monika
core   +1 more source

Possibilities to Improve the Therapy of the Patients with Ureteral Concretions [PDF]

open access: yes, 2017
The aim of the given study was to improve the results of treatment of patients with concretions of the upper third of the ureter.Materials and methods. The clinical trial was carried out as a non-interventional open, controlled, in two groups of patients
Chabanov, P. (Pavel)   +2 more
core   +2 more sources

Three‐Component Synthesis of β‐Ketosulfonamides via Visible‐Light‐Mediated Generation of Sulfamoyl Radicals

open access: yesChemCatChem, Volume 17, Issue 6, March 17, 2025.
A photoredox‐catalyzed three‐component synthesis of β‐ketosulfonamides is described. This reaction utilizes in situ‐generated sulfamoyl radicals as versatile synthetic intermediates. It enables a visible‐light‐mediated, direct fixation of sulfur dioxide, provided as the simple‐to‐handle solid surrogate DABSO, into pharmaceutically relevant sulfonamide ...
Kamil Hofman   +2 more
wiley   +1 more source

PENGARUH PENGOBATAN TAMSULOSIN TERHADAP FUNGSI EREKSI PADA PASIEN BENIGN PROSTATIC HYPERPLASIA [PDF]

open access: yes, 2015
Benign Prostatic Hyperplasia (BPH) sering ditemukan pada orang lanjut usia begitu juga dengan disfungsi ereksi (DE). Salah satu pengobatan BPH berdasarkan Pedoman Penatalaksanaan BPH di Indonesia adalah Tamsulosin.
Harjuna Muhammad
core  

The efficacy of tamsulosin in lower ureteral calculi

open access: yesUrology Annals, 2010
There has been a paradigm shift in the management of ureteral calculi in the last decade with the introduction of new less invasive methods, such as ureterorenoscopy and extracorporeal shock wave lithotripsy (ESWL).Recent studies have reported excellent results with medical expulsive therapy (MET) for distal ureteral calculi, both in terms of stone ...
Himanshu Paul   +4 more
openaire   +4 more sources

Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System

open access: yesPharmacology Research &Perspectives, Volume 13, Issue 1, February 2025.
ABSTRACT The increasing utilization of cannabis products combined with lack of data regarding potential cannabis–prescription drug interactions is concerning. This study aimed to review published case reports and FDA Adverse Event Reporting System (FAERS) spontaneous reports to assess cannabis–drug interactions in persons aged 18 and over. A literature
Maryann R. Chapin   +7 more
wiley   +1 more source

Does the addition of Serenoa repens to tamsulosin improve its therapeutical efficacy in benign prostatic hyperplasia? [PDF]

open access: yes, 2013
Background/Aim. It has been observed that a large number of patients with low urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH)) has been treated with a combination of tamsulosin (TAM) + Serenoa repens (SR) (TAM + SR).
Argirović Aleksandar   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy